Struggling to control your blood pressure?
The purpose of the "Radiance-HTN" study is to demonstrate the efficacy and safety of a medical device intended to treat hypertension in reducing systolic daytime ambulatory blood pressure (ABP) in patients with hypertension.
For more information, please visit https://highbptrial.com/.
Is this Clinical Trial for You?
Study subjects should be between the ages of 18 and 75, and have treatment-resistant high blood pressure on a minimum of 3 blood pressure medications, including a diuretic.
How the Clinical Trial Works
The "Radiance-HTN" Study is evaluating the Paradise® Renal Denervation System, a new approach which may lower your blood pressure and reduce your need for blood pressure medications.
People with high blood pressure typically have overactive renal (kidney) nerves, and it has been shown that calming these overactive nerves can help reduce blood pressure. The Paradise Renal Denervation System was designed to calm these overactive nerves through a one-time, minimally-invasive procedure.
A small catheter is placed in the artery supplying the kidney. Ultrasound energy (sound waves) is delivered for a few seconds to lower the over-activity of the nerves. After both kidneys are treated, the catheter is removed leaving nothing behind.
Location of the Clinical Trial
219 N. Broad Street
The Arnold T. Berman, MD Building, 9th Floor
Philadelphia, PA 19107
Contact us today for more information!
Nancy Katof, BA, CCRC
Clinical Research Coordinator
Principal Investigator: Jesse M. Goldman, MD